Growth Metrics

Biohaven (BHVN) Capital Expenditures (2021 - 2025)

Biohaven has reported Capital Expenditures over the past 5 years, most recently at $8000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $8000.0 for Q4 2025, down 83.67% from a year ago — trailing twelve months through Mar 2026 was $254000.0 (down 93.76% YoY), and the annual figure for FY2025 was $715000.0, down 82.34%.
  • Capital Expenditures reached $8000.0 in Q4 2025 per BHVN's latest filing, down from $13000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.5 million in Q3 2022 and bottomed at $8000.0 in Q4 2025.
  • Median Capital Expenditures over the past 5 years was $461000.0 (2025), compared with a mean of $828647.1.
  • The largest annual shift saw Capital Expenditures soared 395.63% in 2024 before it plummeted 97.87% in 2025.
  • Over 5 years, Capital Expenditures stood at $201000.0 in 2021, then surged by 49.25% to $300000.0 in 2022, then surged by 56.67% to $470000.0 in 2023, then crashed by 89.57% to $49000.0 in 2024, then tumbled by 83.67% to $8000.0 in 2025.
  • Business Quant data shows Capital Expenditures for BHVN at $8000.0 in Q4 2025, $13000.0 in Q3 2025, and $233000.0 in Q2 2025.